Glioblastoma: all 1,951 studies
Page 15 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT02663440Phase 2
- Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)CompletedNCT02658981Phase 1
- Cancer Stem Cell High-Throughput Drug Screening StudyCompletedNCT02654964Phase 1
- Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM PatientsTerminatedNCT02654041Phase 2
- Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent GlioblastomaTerminatedNCT02648633Phase 1
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- POSitron Emission Imaging Using 18F-FDOPA in NeurooncologyCompletedNCT02631655Not applicable
- A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant GliomasStatus unknownNCT02629757Phase 3
- Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene AmplificationCompletedNCT02626364Phase 2
- The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma PatientsStatus unknownNCT02623231Phase 2/3
- mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma MultiformeCompletedNCT02619864Phase 1
- Impact of the Platelet Level in Patients Treated for Glioblastoma With TemozolomidCompletedNCT02617745Phase 2
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS MetastasisCompletedNCT02605746Early Phase 1
- Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWithdrawnNCT02599090Phase 2
- Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before SurgeryWithdrawnNCT02590497Not applicable
- Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaCompletedNCT02590263Phase 1/2
- Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade GliomasStatus unknownNCT02585219
- Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT02575027Not applicable
- Neoadjuvant Nivolumab in GlioblastomaCompletedNCT02550249Phase 2
- Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in GlioblastomaSuspendedNCT02546102Phase 3
- Study of Neurological Complication After Radiotherapy for High Grade GlioblastomaStatus unknownNCT02544178
- Fluorescein vs. iMRI in Resection of Malignant High Grade GliomaWithdrawnNCT02540135Not applicable
- Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed GlioblastomaTerminatedNCT02530502Phase 1
- EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory GlioblastomaWithdrawnNCT02521090Phase 1/2
- Supra-early Post-Surgery Chemotherapy in the Treatment on GBM PatientsStatus unknownNCT02520635
- A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)CompletedNCT02511405Phase 3
- Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed GlioblastomaTerminatedNCT02510950Phase 1
- A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in AustraliaCompletedNCT02507102Not applicable
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsCompletedNCT02502708Phase 1
- A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesCompletedNCT02498665Phase 1
- A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade GliomaCompletedNCT02490930Early Phase 1
- Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot StudyCompletedNCT02474966Phase 2
- Search of Protein Biomarkers in Order to Achieve a Molecular Classification of GliomasCompletedNCT02473484
- qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.CompletedNCT02466828Early Phase 1
- Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With RadiochemotherapyCompletedNCT02458508
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsCompletedNCT02457845Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma PatientsTerminatedNCT02443194Phase 3
- Evaluating Therapeutic Response to Novo-TTFCompletedNCT02441322Not applicable
- Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.TerminatedNCT02433392Phase 1
- The Addition of Chloroquine to Chemoradiation for Glioblastoma,WithdrawnNCT02432417Phase 2
- Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475Status unknownNCT02430363Phase 1/2
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade GliomaTerminatedNCT02414165Phase 2/3
- INC280 Combined With Bevacizumab in Patients With Glioblastoma MultiformeCompletedNCT02386826Phase 1
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed GlioblastomasCompletedNCT02379572Not applicable
- The Addition of Chloroquine to Chemoradiation for GlioblastomaCompletedNCT02378532Phase 1
- Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and CaregiversActive, not recruitingNCT02375841
- Tryptophan Metabolism in Human Brain Tumors-NovocureCompletedNCT02367482
- A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorTerminatedNCT02365662Phase 1
- Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed GlioblastomaCompletedNCT02364206Phase 1/2
- Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With GlioblastomaCompletedNCT02359097Not applicable
- NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First RelapseWithdrawnNCT02348255Phase 2
- Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic GliomaStatus unknownNCT02345824Phase 1
- A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma MultiformeActive, not recruitingNCT02344355Phase 2
- Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT02337426Phase 1
- A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsCompletedNCT02335918Phase 1/2
- Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma MultiformeActive, not recruitingNCT02331498Phase 1/2
- A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First RelapseCompletedNCT02330991Phase 2
- Image-derived Prediction of Response to Chemo-radiation in GlioblastomaTerminatedNCT02329795
- Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaCompletedNCT02311920Phase 1
- Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot StudyCompletedNCT02302235Phase 2
- A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)CompletedNCT02296580Not applicable
- Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBMActive, not recruitingNCT02287428Phase 1
- Glioma Modified Atkins-based Diet in Patients With GlioblastomaCompletedNCT02286167Not applicable
- TMS Electrochemotherapy for Glioblastoma MultiformeWithdrawnNCT02283944Phase 2
- Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed GlioblastomaCompletedNCT02270034Phase 1
- Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed GlioblastomaTerminatedNCT02254954Phase 1
- Safety of BBB Opening With the SonoCloudCompletedNCT02253212Phase 1/2
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompletedNCT02238496Phase 1
- Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT02227901Phase 1
- Prevention of Thrombocytopenia in Glioblastoma PatientsTerminatedNCT02227576Phase 2
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ GlioblastomaTerminatedNCT02209376Phase 1
- A Phase 0 Study of AZD1775 in Recurrent GBM PatientsCompletedNCT02207010Early Phase 1
- Trial of Hypofractionated Radiation Therapy for GlioblastomaCompletedNCT02206230Phase 2
- TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBMCompletedNCT02202993Phase 1
- DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain TumorsCompletedNCT02197169Phase 1
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- The Effects of NVX-108 as a Radiation Sensitizer in GlioblastomaCompletedNCT02189109Phase 1
- Subventricular Zone (SVZ) and Temozolomide in Glioblastoma MultiformeActive, not recruitingNCT02177578Phase 2
- Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaTerminatedNCT02176720Phase 1
- Disease Progression and Treatment-induced Alterations in GlioblastomaStatus unknownNCT02152748
- GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma PatientsCompletedNCT02149225Phase 1
- MRSI to Predict Response to RT/TMZ ± Belinostat in GBMActive, not recruitingNCT02137759Phase 2
- Sapanisertib Before and After Surgery in Treating Patients With Recurrent GlioblastomaTerminatedNCT02133183Phase 1
- Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close PartnerTerminatedNCT02129335
- Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96CompletedNCT02122822Phase 1
- INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II StudyCompletedNCT02104882Phase 1/2
- Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaCompletedNCT02101905Phase 1
- Preoperative Chemoradiation for GlioblastomaCompletedNCT02092038Phase 1
- Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBMTerminatedNCT02085304Phase 1/2
- Spatial Analysis and Validation of Glioblastoma on 7 T MRITerminatedNCT02062372Not applicable
- Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/IrinotecanTerminatedNCT02060955Phase 2
- Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasWithdrawnNCT02055196Phase 1
- A Study of ICT-121 Dendritic Cell Vaccine in Recurrent GlioblastomaCompletedNCT02049489Phase 1
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin TherapyTerminatedNCT02047214Phase 2
- Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological CharacteristicsStatus unknownNCT02047058
- Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed GlioblastomaTerminatedNCT02046187Phase 1/2